Accuray Incorporated (ARAY) Inventory Turnover Ratio, from fourth quarter 2026 to fourth quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Accuray Incorporated  (NASDAQ: ARAY)
 

Accuray Incorporated Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Accuray Incorporated's inventory turnover ratio, the ratio that measures Accuray Incorporated's ability to manage its supply chain, sequentially decreased to 1.93 in the fourth quarter 2026, which does not come as a surprise, as the Accuray Incorporated continue to experience headwinds, which also impact its supply chain. Accuray Incorporated's average inventory processing period in the Jun 30 2026 quarter, has increased to 189 days, from 173 days, in the Mar 31 2026 quarter.

Within Healthcare sector 213 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1328 in the third quarter 2026, to 1513.

ARAY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Accuray Incorporated Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARAY Inventory Turnover Ratio (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Inventory Growth 4.29 % 6.95 % 1.95 % 0.4 % 1.95 %
Y / Y Cost of Sales Growth -26.54 % -2.47 % 5.41 % 0 % -6.52 %
Inventory Turnover Ratio (TTM) 1.93 2.11 2.16 2.14 2.14
ARAY's Total Ranking # 1513 # 1328 # 1081 # 956 # 1239
Average inventory processing period 189 173 169 171 170
Seq. Inventory Growth -6.1 % 11.07 % -9.31 % 10.27 % -3.7 %
Seq. Cost of Sales Growth -17.24 % 1.28 % 16.42 % -24.72 % 9.88 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 92
Healthcare Sector # 214
Overall Market # 1513

Inventory Turnover Ratio Statistics
High Average Low
2.59 2.12 1.63
(Jun 30 2013)   (Dec 31 2020)



ARAY Company Profile >> Back to ARAY Efficiency Comparisons >> Compare ARAY Inventory Turnover Ratio to its Competitors

Financial Statements
Accuray Incorporated's Inventories $ 147 Millions Visit ARAY's Balance sheet
Accuray Incorporated's Cost of Revenues TTM $ 289 Millions Visit ARAY's Income Statement
What are ARAY's Sales? Visit ARAY's Sales by Segment

Other Inventory Turnover Ratios
Accuray Incorporated's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ARAY's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ARAY's Competitors
Inventory Turnover Ratio for ARAY's Suppliers
Inventory Turnover Ratio for ARAY's Customers

You may also want to know
ARAY's Sales Growth Rates ARAY's Pe Price to earnings ratio ARAY's Receivables Turnover Ratio ARAY's Stock Quote
ARAY's Net Income Growth Rates ARAY's Ps Price to Sales ratio ARAY's Sales per Employee ARAY's Asset Turnover Ratio
ARAY's Net Margin ARAY's Pb Price to Book ratio ARAY's Financial Strength Ratios ARAY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions

Date modified: 2026-08-29T04:46:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.